These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1384642)

  • 21. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
    Wilson MJ; Sinha AA
    Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.
    Hu DE; Fan TP
    Br J Pharmacol; 1995 Jan; 114(2):262-8. PubMed ID: 7533611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced effects of monoclonal antibody carboplatin immunoconjugates uptake and anti-tumor effects with angiotensin II and tumor necrosis factor.
    Takeda A; Miyoshi T; Shimada H; Ochiai T; Isono K
    J Chemother; 1999 Apr; 11(2):137-43. PubMed ID: 10326745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood flow influences vascular growth during tumour angiogenesis.
    Nasu R; Kimura H; Akagi K; Murata T; Tanaka Y
    Br J Cancer; 1999 Feb; 79(5-6):780-6. PubMed ID: 10070869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of endothelin-1 on responses of isolated blood vessels to vasoconstrictor agonists.
    Wong-Dusting HK; La M; Rand MJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S236-8. PubMed ID: 1725343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of tumour blood flow modification in two rat tumour systems using endothelin-1 and angiotensin II: influence of tumour size on angiotensin II response.
    Bell KM; Prise VE; Shaffi KM; Chaplin DJ; Tozer GM
    Int J Cancer; 1996 Sep; 67(5):730-8. PubMed ID: 8782666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple therapy with octreotide, galanin and serotonin induces necrosis and increases apoptosis of a rat colon carcinoma.
    El-Salhy M; Sitohy B
    Regul Pept; 2002 Oct; 108(2-3):55-62. PubMed ID: 12220727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth.
    Thompson WD; Shiach KJ; Fraser RA; McIntosh LC; Simpson JG
    J Pathol; 1987 Apr; 151(4):323-32. PubMed ID: 2438394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte entry into inflammatory tissues in vivo. Qualitative differences of high endothelial venule-like vessels in sponge matrix allografts vs isografts.
    Bishop DK; Jutila MA; Sedmak DD; Beattie MS; Orosz CG
    J Immunol; 1989 Jun; 142(12):4219-24. PubMed ID: 2470821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice.
    Runkel S; Hunter N; Milas L
    Radiat Res; 1991 May; 126(2):237-43. PubMed ID: 1708892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice.
    Buttery LD; Springall DR; Andrade SP; Riveros-Moreno V; Hart I; Piper PJ; Polak JM
    J Pathol; 1993 Dec; 171(4):311-9. PubMed ID: 7512644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Sponge Implant Model of Angiogenesis.
    Andrade SP; Ferreira MA
    Methods Mol Biol; 2016; 1430():333-43. PubMed ID: 27172965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation.
    Zlotecki RA; Baxter LT; Boucher Y; Jain RK
    Microvasc Res; 1995 Nov; 50(3):429-43. PubMed ID: 8583955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis, endothelial cell functions, and tumor cell growth in biodegradable and nonbiodegradable devices.
    Zhao X; Kalliomäki S; Wang X; Kalliomäki J; Andersson R
    J Biomed Mater Res B Appl Biomater; 2005 Aug; 74(2):774-81. PubMed ID: 15988753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine angiogenic factor induces vascularization of collagen sponges in guinea-pigs.
    Lindenbaum ES; Kaufman T; Beach D; Maroudas NG
    Burns; 1989 Aug; 15(4):225-9. PubMed ID: 2475139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    Clin Invest Med; 1993 Jun; 16(3):177-86. PubMed ID: 8365045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local drug delivery system: inhibition of inflammatory angiogenesis in a murine sponge model by dexamethasone-loaded polyurethane implants.
    Moura SA; Lima LD; Andrade SP; Da Silva-Cunha A; Órefice RL; Ayres E; Da Silva GR
    J Pharm Sci; 2011 Jul; 100(7):2886-95. PubMed ID: 21283986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
    Ferreira MA; Barcelos LS; Teixeira MM; Bakhle YS; Andrade SP
    Life Sci; 2007 Jun; 81(3):210-7. PubMed ID: 17588613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of vasopressor agents on the vessel wall].
    Lindner E
    Med Welt; 1975 May; 26(21):1017-24. PubMed ID: 1095885
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats.
    van der Veen AH; Seynhaeve AL; Breurs J; Nooijen PT; Marquet RL; Eggermont AM
    Br J Cancer; 1999 Feb; 79(3-4):433-9. PubMed ID: 10027309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.